MGMT and glioblastoma: The methylation levels of four CpGs (CpG 17, 18, 21, and 22) of enhancer 3 (hs699), located upstream of the MGMT promoter and downstream of enhancer 2, were significantly higher in the MGMT-expressing GBM samples than in the -non-expressing GBM samples.